- Home
- JFIN vs OLMA Comparison
JFIN vs OLMA Comparison
Compare JFIN & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JFIN
- OLMA
- Stock Information
- Founded
- JFIN 2011
- OLMA 2006
- Country
- JFIN China
- OLMA United States
- Employees
- JFIN N/A
- OLMA N/A
- Industry
- JFIN Finance: Consumer Services
- OLMA Biotechnology: Pharmaceutical Preparations
- Sector
- JFIN Finance
- OLMA Health Care
- Exchange
- JFIN Nasdaq
- OLMA Nasdaq
- Market Cap
- JFIN 682.1M
- OLMA 560.7M
- IPO Year
- JFIN 2019
- OLMA 2020
- Fundamental
- Price
- JFIN $11.15
- OLMA $10.48
- Analyst Decision
- JFIN
- OLMA Strong Buy
- Analyst Count
- JFIN 0
- OLMA 5
- Target Price
- JFIN N/A
- OLMA $24.00
- AVG Volume (30 Days)
- JFIN 90.9K
- OLMA 1.2M
- Earning Date
- JFIN 11-19-2025
- OLMA 11-11-2025
- Dividend Yield
- JFIN 7.06%
- OLMA N/A
- EPS Growth
- JFIN 33.85
- OLMA N/A
- EPS
- JFIN 4.21
- OLMA N/A
- Revenue
- JFIN $908,895,698.00
- OLMA N/A
- Revenue This Year
- JFIN N/A
- OLMA N/A
- Revenue Next Year
- JFIN N/A
- OLMA N/A
- P/E Ratio
- JFIN $2.68
- OLMA N/A
- Revenue Growth
- JFIN 8.19
- OLMA N/A
- 52 Week Low
- JFIN $5.18
- OLMA $2.86
- 52 Week High
- JFIN $19.23
- OLMA $13.51
- Technical
- Relative Strength Index (RSI)
- JFIN 44.45
- OLMA 70.04
- Support Level
- JFIN $10.18
- OLMA $8.01
- Resistance Level
- JFIN $11.64
- OLMA $11.54
- Average True Range (ATR)
- JFIN 0.46
- OLMA 0.79
- MACD
- JFIN 0.17
- OLMA 0.14
- Stochastic Oscillator
- JFIN 73.97
- OLMA 72.61
About JFIN Jiayin Group Inc.
Jiayin Group Inc is China's technology service group. It is an enterprise engaged in technological innovation services. It is committed to using big data, cloud computing, artificial intelligence and other technologies to connect consumers and financial institutions in consumption scenarios so that every user can enjoy efficient and convenient technology services. The company has engraved technological innovation into the company's development genes since its establishment, adheres to the dual drive of digital plus technology, and focuses on building a cloud service platform and intelligent risk control system with big data drive as the core concept.
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.